BG61839B1 - Индолови производни като nmda-антагонисти - Google Patents

Индолови производни като nmda-антагонисти Download PDF

Info

Publication number
BG61839B1
BG61839B1 BG100511A BG10051196A BG61839B1 BG 61839 B1 BG61839 B1 BG 61839B1 BG 100511 A BG100511 A BG 100511A BG 10051196 A BG10051196 A BG 10051196A BG 61839 B1 BG61839 B1 BG 61839B1
Authority
BG
Bulgaria
Prior art keywords
solution
indole
dichloro
carboxylic acid
ylidenemethyl
Prior art date
Application number
BG100511A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG100511A (en
Inventor
Alfredo Cugola
Romano Di Fabio
Giorgio Pentassuglia
Original Assignee
Glaxo Wellcome Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Wellcome Spa filed Critical Glaxo Wellcome Spa
Publication of BG100511A publication Critical patent/BG100511A/xx
Publication of BG61839B1 publication Critical patent/BG61839B1/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
BG100511A 1993-10-14 1996-04-16 Индолови производни като nmda-антагонисти BG61839B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939321221A GB9321221D0 (en) 1993-10-14 1993-10-14 Heterocyclic compounds
PCT/EP1994/003359 WO1995010517A1 (en) 1993-10-14 1994-10-12 Indole derivatives as nmda antagonists

Publications (2)

Publication Number Publication Date
BG100511A BG100511A (en) 1996-11-29
BG61839B1 true BG61839B1 (bg) 1998-07-31

Family

ID=10743550

Family Applications (1)

Application Number Title Priority Date Filing Date
BG100511A BG61839B1 (bg) 1993-10-14 1996-04-16 Индолови производни като nmda-антагонисти

Country Status (27)

Country Link
US (3) US5760059A (cs)
EP (1) EP0723541A1 (cs)
JP (1) JPH09503770A (cs)
CN (1) CN1070490C (cs)
AP (1) AP574A (cs)
AU (1) AU681194B2 (cs)
BG (1) BG61839B1 (cs)
CA (1) CA2171449A1 (cs)
CO (1) CO4290355A1 (cs)
CZ (1) CZ92396A3 (cs)
FI (1) FI961628A0 (cs)
GB (1) GB9321221D0 (cs)
HU (1) HU219710B (cs)
IL (1) IL111294A (cs)
IS (1) IS4219A (cs)
MY (1) MY112411A (cs)
NO (1) NO309861B1 (cs)
NZ (1) NZ274179A (cs)
OA (1) OA10578A (cs)
PE (1) PE21995A1 (cs)
PL (1) PL179568B1 (cs)
RU (1) RU2144535C1 (cs)
SG (1) SG49013A1 (cs)
SK (1) SK44996A3 (cs)
TW (1) TW283144B (cs)
WO (1) WO1995010517A1 (cs)
ZA (1) ZA947948B (cs)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9321221D0 (en) * 1993-10-14 1993-12-01 Glaxo Spa Heterocyclic compounds
GB9704498D0 (en) * 1997-03-05 1997-04-23 Glaxo Wellcome Spa Chemical compound
GB9704499D0 (en) * 1997-03-05 1997-04-23 Glaxo Wellcome Spa Method of manufacture
AU3195600A (en) * 1999-03-23 2000-10-09 Sumitomo Pharmaceuticals Company, Limited Tricyclic indole-2-carboxylic acid compound used as nmda receptor antagonist
RU2209041C2 (ru) * 2000-06-15 2003-07-27 Новосибирский научно-исследовательский институт травматологии и ортопедии Способ лечения церебрального вазоспазма
DE10153346A1 (de) 2001-10-29 2004-04-22 Grünenthal GmbH Substituierte Indole
WO2003039540A2 (en) * 2001-11-09 2003-05-15 Sepracor Inc. D-amino acid oxidase inhibitors for learning and memory
NZ548212A (en) 2003-12-29 2010-07-30 Sepracor Inc Pyrrole and pyrazole DAAO inhibitors
WO2007006003A2 (en) 2005-07-06 2007-01-11 Sepracor Inc. Combinations of eszopiclone and trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-n-methyl-1-napthalenamine or trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine, and methods of treatment of menopause and mood, anxiety, and cognitive disorders
CA2631232A1 (en) * 2005-12-01 2007-06-07 F. Hoffmann-La Roche Ag Novel vinylogous acids derivatives
KR101294014B1 (ko) 2006-01-06 2013-08-09 선오비온 파마슈티컬스 인코포레이티드 모노아민 재흡수 저해제로서의 시클로알킬아민
US8053603B2 (en) * 2006-01-06 2011-11-08 Sunovion Pharmaceuticals Inc. Tetralone-based monoamine reuptake inhibitors
DK2816024T3 (en) 2006-03-31 2017-10-30 Sunovion Pharmaceuticals Inc CHIRALE AMINER
US7884124B2 (en) * 2006-06-30 2011-02-08 Sepracor Inc. Fluoro-substituted inhibitors of D-amino acid oxidase
US7579370B2 (en) * 2006-06-30 2009-08-25 Sepracor Inc. Fused heterocycles
US20080082066A1 (en) * 2006-10-02 2008-04-03 Weyerhaeuser Co. Crosslinked carboxyalkyl cellulose fibers having non-permanent and temporary crosslinks
US7902252B2 (en) * 2007-01-18 2011-03-08 Sepracor, Inc. Inhibitors of D-amino acid oxidase
US20090099248A1 (en) * 2007-01-18 2009-04-16 Sepracor Inc. Inhibitors of d-amino acid oxidase
MX2009012685A (es) 2007-05-31 2009-12-14 Sepracor Inc Cicloalquilaminas sustituidas con fenilo como inhibidores de la reabsorcion de monoamina.
WO2010017418A1 (en) * 2008-08-07 2010-02-11 Sepracor Inc. Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase
JP2010235597A (ja) * 2009-03-10 2010-10-21 Santen Pharmaceut Co Ltd 4,6−ジクロロ−1h−インドール−2−カルボン酸誘導体又はその塩を有効成分として含有する視神経障害の予防又は治療剤
WO2011017634A2 (en) * 2009-08-07 2011-02-10 Sepracore Inc. Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase
AU2012321345B2 (en) 2011-10-03 2016-03-17 The University Of Utah Research Foundation Application of 5-HT6 receptor antagonists for the alleviation of cognitive deficits of down syndrome
SG10202102125SA (en) 2014-04-30 2021-04-29 Yufeng Tseng Use of known compounds as d-amino acid oxidase inhibitors
EP4289425A3 (en) 2016-09-14 2024-08-07 Yufeng Jane Tseng Novel substituted benzimidazole derivatives as d-amino acid oxidase (daao) inhibitors

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256673A (en) * 1983-11-25 1993-10-26 Merck Patent Gesellschaft Mit Beschrankter Haftung Indole-3-yl-A-tetrahydropyridyl or piperidyl compounds
US4960786A (en) * 1989-04-24 1990-10-02 Merrell Dow Pharmaceuticals Inc. Excitatory amino acid antagonists
PT93943A (pt) * 1989-05-05 1991-02-08 Searle & Co Processo para a preparacao de composicoes contendo compostos indole-2-carboxilato para tratamento de perturbacoes do snc
DE4101686A1 (de) * 1991-01-22 1992-07-23 Merck Patent Gmbh Indolderivate
US5284862A (en) * 1991-03-18 1994-02-08 Warner-Lambert Company Derivatives of 2-carboxyindoles having pharmaceutical activity
US5145845A (en) * 1991-05-14 1992-09-08 Warner-Lambert Co. Substituted 2-carboxylindoles having pharmaceutical activity
EP0545478A1 (en) * 1991-12-03 1993-06-09 MERCK SHARP & DOHME LTD. Heterocyclic compounds as tachykinin antagonists
GB9208492D0 (en) * 1992-04-16 1992-06-03 Glaxo Spa Heterocyclic compounds
CZ181493A3 (en) * 1992-09-10 1994-03-16 Lilly Co Eli The use of rhodanine derivative for the preparation of a pharmaceutical composition reducing level of sugar in blood and for treating alzheimer's disease
DE4333254A1 (de) * 1993-09-30 1995-04-06 Merck Patent Gmbh Piperidine und Piperazine
GB9321221D0 (en) * 1993-10-14 1993-12-01 Glaxo Spa Heterocyclic compounds

Also Published As

Publication number Publication date
IL111294A (en) 1998-12-06
AU7813394A (en) 1995-05-04
AP9400685A0 (en) 1994-10-31
IS4219A (is) 1995-04-15
CN1070490C (zh) 2001-09-05
NZ274179A (en) 1998-01-26
MY112411A (en) 2001-06-30
ZA947948B (en) 1995-05-23
EP0723541A1 (en) 1996-07-31
NO961475D0 (no) 1996-04-12
GB9321221D0 (en) 1993-12-01
TW283144B (cs) 1996-08-11
BG100511A (en) 1996-11-29
NO309861B1 (no) 2001-04-09
JPH09503770A (ja) 1997-04-15
NO961475L (no) 1996-04-12
HU219710B (hu) 2001-06-28
AP574A (en) 1997-01-30
US5962496A (en) 1999-10-05
OA10578A (en) 2002-06-07
IL111294A0 (en) 1994-12-29
RU2144535C1 (ru) 2000-01-20
AU681194B2 (en) 1997-08-21
CO4290355A1 (es) 1996-04-17
CN1133042A (zh) 1996-10-09
FI961628A7 (fi) 1996-04-12
PL179568B1 (pl) 2000-09-29
PL313969A1 (en) 1996-08-05
US5760059A (en) 1998-06-02
FI961628A0 (fi) 1996-04-12
US6100289A (en) 2000-08-08
SK44996A3 (en) 1997-01-08
CZ92396A3 (en) 1996-08-14
SG49013A1 (en) 1998-05-18
HUT76065A (en) 1997-06-30
PE21995A1 (es) 1995-08-14
HU9600969D0 (en) 1996-06-28
CA2171449A1 (en) 1995-04-20
WO1995010517A1 (en) 1995-04-20

Similar Documents

Publication Publication Date Title
RU2144535C1 (ru) Производные индола
AP480A (en) 3-Substituted indole 2-carboxylic acid derivatives.
EP1487822B1 (en) Pyrrole-2,5-dione derivatives and their use as gsk-3 inhibitors
US5686461A (en) Indole derivatives
KR20110098827A (ko) 키나제 억제제로서 유용한 카르바졸 카르복스아미드 화합물
AP877A (en) Tetrahydroquinoline derivatives as EAA antagonists.
AU708291B2 (en) Indole derivatives as EAA antagonists
HK1219104A1 (zh) 激酶抑制剂
CZ292379B6 (cs) Tetrahydrochinolinové deriváty, způsob jejich výroby a farmaceutický prostředek s jejich obsahem
JP5159630B2 (ja) 縮環複素環誘導体
WO1995007887A1 (en) Indole derivatives as antagonists of excitatory amino acids
CN121079291A (zh) 作为ripk1抑制剂的异噁唑烷及其使用